- GBP/USD remains depressed around multi-day low after heaviest drop in a month.
- UK’s vaccine optimism can’t supersede the US dollar strength, risk-off mood.
- British inflation, activity numbers can offer immediate directions but qualitative catalysts remain as the key.
GBP/USD stands on slippery ground, refreshing the lowest level since February, while taking offers near 1.3740 during the early Asian session on Wednesday. In doing so, the cable respects the US dollar’s broad strength amid risk-off mood while ignoring the coronavirus (COVID-19) vaccine optimism at home.
US dollar index (DXY) rose to a two-week top the previous day as Fed policymakers kept rejecting the reflation fears but couldn’t convince the markets. Among them, Fed Chair Jerome Powell and Dallas Federal Reserve President Robert Kaplan were optimistic over the economic recovery and rate hikes but Federal Reserve Governor Lael Brainard and St. Louis Fed President James Bullard offered mixed signals afterward. Also, US Treasury Secretary Janet Yellen defended the Biden administration’s stimulus while turning down the tax-hike fears to favor the greenback.
Also contributing to the USD rise were fears of a full-fledged West versus China tussle after an alliance among the US, the UK, Canada and the European Union (EU) harshly criticized human rights violations in Xinjiang. Brussels went a step farther to levy sanctions on Beijing diplomats which the dragon nation retaliated.
It should be noted that the extension of the virus-led lockdowns in Germany and the Netherlands also contribute to the risk-off mood while the bloc’s efforts to test the UK’s covid vaccine supply exerted additional downside pressure on the sentiment.
At home, mixed employment figures and the government’s readiness to jab school children from August fail to offer any clear direction to the GBP/USD moves. On the same line were comments from UK Chancellor Rishi Sunak who cited challenges for the global economy.
While portraying the sentiment, Wall Street benchmarks flashed red and the US 10-year Treasury yields also dropped on Tuesday whereas stock futures are currently directionless.
Moving on, the UK’s Consumer Price Index (CPI) data for February, expected 0.8% versus 0.7%, will be the immediate catalysts for GBP/USD ahead of the preliminary readings of March month’s activity numbers. It should, however, be noted that the risk catalyst remains the key to follow.
A sustained break of 50-day SMA of 1.3830 and bearish MACD directs GBP/USD sellers towards a 100-day SMA level of 1.3617. However, any further downside depends upon the pair’s ability to pierce off February’s low of 1.3566.
Additional important levels
|Today last price||1.3736|
|Today Daily Change||-0.0128|
|Today Daily Change %||-0.92%|
|Today daily open||1.3864|
|Previous Daily High||1.3877|
|Previous Daily Low||1.3818|
|Previous Weekly High||1.4002|
|Previous Weekly Low||1.3809|
|Previous Monthly High||1.4243|
|Previous Monthly Low||1.3566|
|Daily Fibonacci 38.2%||1.384|
|Daily Fibonacci 61.8%||1.3854|
|Daily Pivot Point S1||1.3829|
|Daily Pivot Point S2||1.3794|
|Daily Pivot Point S3||1.377|
|Daily Pivot Point R1||1.3888|
|Daily Pivot Point R2||1.3912|
|Daily Pivot Point R3||1.3947|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.